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AbstrACt
Objectives We conducted a Pakistan-wide community-
based survey on the prevalence of type 2 diabetes using 
glycated haemoglobin (HbA1c) as the screening test. The 
aim was to estimate diabetes prevalence across different 
demographic groups as well as all regions of Pakistan.
Design, settings and participants Multistaged stratified 
cluster sampling was used for the representative selection 
of people aged ≥20 years, residing in 378 sampled 
clusters of 16 randomly selected districts, in this cross-
sectional study. Eligible participants had blood drawn 
for HbA1c analyses at field clinics near to their homes. 
The oral glucose tolerance test (OGTT) was conducted 
on a subsample of the participants. Overall and stratified 
prevalence of type 2 diabetes and its association with risk 
factors were estimated using logistic regression models.
Main outcome measures Prevalence of prediabetes and 
type 2 diabetes.
results Of 18 856 eligible participants the prevalence of 
prediabetes was 10.91% (95% CI 10.46 to 11.36, n=2057) 
and type 2 diabetes was 16.98% (95% CI 16.44 to 17.51, 
n=3201). Overall, the mean HbA1c level was 5.62% (SD 
1.96), and among newly diagnosed was 8.56% (SD 2.08). 
The prevalence was highest in age 51–60 years (26.03%, 
p<0.001), no formal education (17.66%, p<0.001), class 
III obese (35.09%, p<0.001), family history (31.29%, 
p<0.001) and female (17.80%, p=0.009). On multivariate 
analysis, there was a significant association between type 
2 diabetes and older age, increase in body mass index 
and central obesity, positive family history, and having 
hypertension and an inverse relation with education as a 
categorical variable. On a subsample (n=1027), summary 
statistics for diagnosis of diabetes on HbA1c showed a 
sensitivity of 84.7%, specificity of 87.2% and area under 
the receiver operating characteristic curve 0.86, compared 
with OGTT.
Conclusions The prevalence of type 2 diabetes and 
prediabetes is much higher than previously thought in 
Pakistan. Comprehensive strategies need to be developed 
to incorporate screening, prevention and treatment of type 
2 diabetes at a community level.
bACkgrOunD  
Type 2 diabetes mellitus is one of the most 
common public health issues worldwide and 
its incidence is on the rise, particularly in 
middle-income and low-income countries.1 
When associated with complications, type 2 
diabetes can have a profound impact on the 
person with consequences also for the society 
as a whole. Diabetes was previously thought 
to be a disease of the affluent and mostly 
prevalent in urban areas but due to urbanisa-
tion, change in nutrition and a more seden-
tary lifestyle for many people, it has affected 
middle-income and low-income nations, 
including Pakistan.2 
Pakistan is a South Asian country with 
an area of 796 095 km2 and a population of 
207.7 million people.3 In terms of popula-
tion, Pakistan is the sixth most populous 
country and is the 36th largest country by 
geographical area in the world. Before 2018, 
the only previous national diabetes survey 
in Pakistan in 1999 (published in 2007), 
strengths and limitations of this study
 ► Our study has the strength that we carried out gly-
cated haemoglobin (HbA1c) on all participants and 
oral glucose tolerance test (OGTT) on a subsample.
 ► Furthermore, this is the largest ever national preva-
lence study of type 2 diabetes mellitus from Pakistan 
to date and the first community-based national 
study to use HbA1c as the diagnostic tool. 
 ► The relatively low number (n=1027) of 75 g OGTT. 
Nevertheless, the specificity and sensitivity of 
HbA1c versus OGTT was good.
 ► We had to exclude 16% of recruited participants be-
cause of anaemia.
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reported the prevalence of type 2 diabetes as 11% using 
the oral glucose tolerance test (OGTT).4 5 Part of the 
same survey separately reported the prevalence of type 2 
diabetes in different provinces of Pakistan.4 6–8 The Inter-
national Diabetes Federation (IDF) reported in its Atlas 
5th edition the prevalence for Pakistan to be 6.8%, aged 
20–79 years,9 but healthcare professionals with local 
insight always believed this to be an underestimate. Subse-
quently, there were conflicting findings with prevalence 
ranging from7.2% to 19.21% in different regions of the 
country.5
The American Diabetes Association (ADA) criteria for 
the diagnosis of diabetes require either fasting plasma 
glucose (FPG) or 75 gm OGTT, which is time-consuming, 
requires fasting and may not always be reproducible.10 11 
In 2009, the International Expert Committee on diabetes 
proposed new diagnostic criteria based on glycated 
haemoglobin (HbA1c), which captures chronic glucose 
exposure.12 The proposed diagnostic threshold of 6.5% 
(48 mmol/mol) was based on retinopathy risk at different 
levels of HbA1c as was the case with FPG and OGTT. This 
report was followed by a recommendation from the ADA 
that an HbA1c level of 6.5% (48 mmol/mol) be used as 
the diagnostic cut-off for the diagnoses of diabetes (this 
has not been validated in Pakistan).13
A previous national-level type 2 diabetes survey was 
conducted in 1999 with a sample size of 5433 using 
OGTT. In the study described in this paper, we investi-
gated the prevalence of type 2 diabetes (using the HbA1c 
test) and its distribution across gender, age, rural and 
urban, education, body mass index (BMI) WHO and 
Asian cut-offs, family history, smoking and blood pres-
sure among a large sample across Pakistan, aged 20 years 
and above. A subsample was tested to explore the diag-
nostic accuracy of HbA1c for diagnosis of type 2 diabetes, 
compared with the 2-hour OGTT.
MethODs
The Department of Diabetes, Endocrine and Metabolic 
Diseases, Hayatabad and Department of Health, Govern-
ment of Khyber Pakhtunkhwa, Pakistan with technical 
support from Institute of Public Health, Khyber Medical 
University Peshawar Pakistan, University of Manchester 
UK and Pakistan Endocrine Society conducted a nation-
wide cross-sectional study for the prevalence of type 2 
diabetes starting from April 2017 to November 2017. 
Three teams of trained field workers under the supervi-
sion of epidemiologists collected basic demographic data 
and blood samples from the selected sample. The study 
sample was selected based on a stratified two-stage cluster 
design, including all metropolitan cities of Pakistan and 
randomly selected districts (both rural and urban settings) 
within each province. The sample included districts from 
central and south of Punjab province (Lahore, Multan, 
Bahawalpur, Rahim Yar Khan), interior Sindh (Larkana, 
Dadoo, Sukkur), central Sindh (Karachi), northern 
Khyber Pakhtunkhwa (KP) (Haripur), central (Peshawar) 
and southern KP province (Karak), Baluchistan province 
(Quetta), capital territory (Rawalpindi-Islamabad), Azad 
Jammu Kashmir (AJK) (Muzaffarabad), Frontier Region 
Peshawar and the Khyber Agency in Federal Adminis-
tered Tribal Area (FATA).
sample size and sampling methodology
The sample size was estimated for the provinces of the 
country based on recent census results. The sample size 
was estimated based on an expected prevalence of 12% 
with 20% relative precision and a design effect of 2.6 For a 
95% CI and an additional adjustment of 32% for non-re-
sponders, keeping in view an exclusion rate due to an 
expected high prevalence of anaemia, the sample size was 
4407 approximated to 4500 in order to have 50 subjects 
from each cluster. All provinces were included as was the 
Federal territory. AJK and FATA were considered as one 
province for the survey purpose because of their small 
size of the population. The number of eligible subjects 
was 4500×5=22 500.
Three districts were randomly selected from each prov-
ince and the sample size was equally divided on these 
districts. Fifteen hundred subjects (30 clusters, 50 subjects 
per cluster) were examined in each district. The sample 
was proportionately divided among urban and rural 
areas. Probability proportionate to size (PPS) method was 
used to select clusters from villages in the rural settings of 
the district. In urban settings, clusters were selected from 
charges and circles (defined in the national census) using 
the PPS method.
Maps were obtained from the census office of selected 
villages/charges/circles (V/C/C). Maps of each V/C/C 
was divided into equal segments such that each segment 
had approximately 50 persons aged 20 years and above. 
One segment was randomly selected and every house 
within the segment was included. All persons aged 20 
years and above living in that house were examined until 
the 50 number was reached. Any person who was absent 
on the day of survey until evening, was terminally ill, who 
fitted into exclusion criteria or who refused were marked 
as non-responders.
Conditions that may affect HbA1c including anaemic 
subjects with haemoglobin <120 g/L in women and 
<140 g/L in men, self-reported renal and hepatic dysfunc-
tion, recent blood transfusion and use of erythropoietin, 
age below 20 years or refusal to participate resulted in 
exclusion. Face-to-face interview was conducted at the 
participant’s home to collect information on demo-
graphics (including age, gender, residential area, formal 
education, family history of diabetes and smoking status) 
using a paper questionnaire in local languages. Eligible 
participants were called to a central point established 
in the hujra (local public gathering place), where their 
haemoglobin was tested using the Mission Plus Haemo-
globin Metre (reflectance photometer technique) (Acon 
Laboratories, San Diego, USA) (coefficient of variance 
(CV): 3%). Blood pressure was measured using an auto-
mated digital blood pressure monitor Konfort Model 
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AS-351 in the lying position with the average of three 
readings was recorded. Weight in kilograms and height in 
metres was recorded and used to calculate BMI.
Diabetes status was assessed for HbA1c on blood samples 
using the National Glycohemoglobin Standardisation 
Programme certified FIA 8000 immunoassay analyser 
(lateral flow chromatography colloidal gold) traceable 
to diabetes control and complication trial (DCCT) refer-
ence method (CV: 3%–5%). To compare the results 
from HbA1c, 2-hour OGTT was conducted on a random 
sample of participants from all clusters (n=1027) in the 
specified standard laboratory using Cobas C311 (Roche 
Diagnostics, Mannheim, Germany). Participants were 
given vouchers for free OGTT test within 7 days in a 
nearby laboratory.
Definitions
Age was categorised into six groups: 20–30, 31–40, 
41–50, 51–60 and 61 and above years. The residential 
area was classified as urban and rural based on local 
government criteria. Formal education status was self-re-
ported and was categorised as no formal education, 
primary, secondary and graduation/postgraduation. 
BMI was categorised on WHO criteria (1995) into under-
weight (<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), 
overweight (25–29.9 kg/m2), class I obese (30–34.9 kg/
m2), class II obese (35–39.9 kg/m2) and class III obese 
(>40 kg/m2). Waist circumference (WC) was categorised 
into normal weight (0–93.99), overweight (94–102) and 
obese (102 and above). Waist-to-hip ratio (WHR) was 
categorised into normal weight (0–0.89), overweight 
(0.90–0.99) and obese (1 and above).14 The family 
history of diabetes was categorised to negative or positive 
on the basis of the participant’s self-reporting, based on 
physician’s diagnoses. Smoking status was categorised as 
never, ex or current smoker. Systolic and diastolic blood 
pressure was measured using a standard procedure and 
hypertension was defined on a blood pressure measure-
ment of ≥140/90 mm Hg or antihypertensive medication. 
Patients were considered as known type 2 diabetes based 
on self-reporting and/or being on dietary or exercise 
advice, oral antidiabetes medications or insulin. This 
self-reported group of patients could either be on single 
medications or on different drug combinations or diet 
and exercise therapy.
Type 2 diabetes was diagnosed based on HbA1c results 
in keeping with the WHO levels for non-diabetes (<5.69% 
DCCT aligned/38 mmol/mol International Federation 
of Clinical Chemistry (IFFC) units), prediabetes (5.7%–
6.49% DCCT aligned/39–47 mmol/mol IFFC units), 
diabetes (≥6.5% DCCT aligned/48 mmol/mol IFFC 
units). For univariate and multivariate logistic regres-
sion models, diabetes was dichotomised to no (0; HbA1c 
level <6.5) and yes (1; HbA1c level ≥6.5).
Statistical analyses
Differences in the characteristics of participants by 
diabetes category were analysed using the χ² test for 
categorical data and analysis of variance for continuous 
data. We examined the association between diabetes and 
risk factors, that is, age, gender, residence area, educa-
tion, BMI, family history of diabetes, smoking, systolic 
and diastolic blood pressure, using univariate and multi-
variate logistic regression models. Multivariate regression 
analysis included all these variables.
Taking OGTT as the standard on a subsample, the diag-
nostic accuracy summary statistics (sensitivity, specificity, 
area under the  receiver operating characteristic (ROC) 
curve, positive and negative predictive value) for the diag-
nosis of diabetes using HbA1c were determined. All statis-
tical analyses were performed using Stata V.14 (StataCorp, 
College Station, Texas, USA). Statistical significance was 
defined as p<0.05 and analysis were adjusted for the 
cluster design.
Patient and public involvement statement
Patients were not involved in the study conception or 
design. There was consultation with interested represen-
tative public bodies but not with individual members of 
the public.
results
Of the 22 500 participants, 3644 (16%) were anaemic and 
therefore excluded from the study. Out of the remaining, 
18 856 participants aged 20 years and above were exam-
ined from 378 clusters of which 216 were rural generating 
a response rate of 84%. The mean age was 45.23 years (SD 
13.97 years). Most of the participants 10 116 (53.55%) 
were men, 4148 (21.96%) were hypertensive and those 
with higher blood pressure were advised to check their 
blood pressure by visiting their doctors. Majority of the 
participants, 13 834 (73.24%), had no formal education 
and 1209 (6.40%) had graduated; 6010 (31.81%) had 
a family history of type 2 diabetes. Overall, on WHO 
cut-off 345 (1.83%) were underweight, 6839 (36.20%) 
normal weight, 8038 (42.55%) overweight, 2864 (15.16%) 
class I obese, 633 (3.35%) class II obese and 172 (0.91%) 
class III obese. On WC cut-off (n=12 865), 8574 (66.64%) 
were normal weight, 2318 (18.02%) were overweight and 
1974 (15.34%) were obese. On central obesity cut-off 
(WHR, n=12 865), 4271 (33.20%) were normal weight, 
7467 (58.04%) were overweight and 1127 (8.76%) were 
obese. Mean systolic blood pressure was 126.30 mm Hg 
(SD 14.2) and diastolic blood pressure was 83.24 mm Hg 
(SD 10.2).
Overall, 3201 subjects (16.98%, 95% CI 16.44 to 
17.51) had type 2 diabetes based on HbA1c screening. 
Prediabetes was present in 2057 subjects 10.91% (95% 
CI 10.46 to 11.36). The mean HbA1c level of the entire 
cohort (n=18 856) was 5.62% (SD 1.96), among known 
type 2 diabetes (n=2179) had 8.68% (SD 2.70) and newly 
diagnosed type 2 diabetes (n=1577) had 8.56% (SD 2.08). 
The prevalence of diabetes differed significantly by age, 
education, BMI, WC, WHR, family history and blood pres-
sure (table 1) (figure 1). The prevalence of diabetes was 
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Table 1 Characteristics of the participants by diabetes categories (n=18 856)
Non-diabetic N (%) Prediabetic N (%) Diabetic N (%) P value
13 598 (72.11) 2057 (10.91) 3201 (16.98)
Age (years)
20–30 2772 (20.37) 218 (10.60) 176 (5.52) <0.001
31–40 3503 (25.74) 425 (20.66) 511 (16.01)
41–50 3802 (27.94) 654 (31.79) 1033 (32.37)
51–60 1955 (14.37) 412 (20.03) 833 (26.10)
61 and above 1576 (11.58) 348 (16.92) 638 (19.99)
Gender
Male 7363 (54.15) 1099 (53.43) 1638 (51.17) 0.010
Female 6235 (45.85) 958 (46.57) 1563 (48.83)
Education
No formal education 9853 (72.41) 1516 (73.70) 2439 (76.43) <0.001
Primary 1936 (14.23) 354 (17.21) 452 (14.16)
Secondary 818 (6.01) 99 (4.81) 184 (5.77)
Graduation 1001 (7.36) 88 (4.28) 116 (3.64)
 Area
Urban 9117 (67.00) 1213 (58.97) 1932 (60.55) <0.001
Rural 4491 (33.00) 844 (41.03) 1259 (39.45)
Family history
Negative 10 325 (75.93) 1210 (58.82) 1320 (41.24) <0.001
Positive 3273 (24.07) 847 (41.18) 1881 (58.76)
Smoking
Never 12 682 (93.26) 1893 (92.03) 2937 (91.75) 0.008
Ex-smoker 275 (2.02) 49 (2.38) 91 (2.84)
Current smoker 641 (4.71) 115 (5.59) 173 (5.40)
Systolic BP (mean±SD) 124.98 128.17 130.77 0.020
Diastolic BP (mean±SD) 82.75 84.13 84.84 0.006
BMI (kg/m2)
Underweight (<18.5) 279 (2.05) 31 (1.51) 35 (1.09) <0.001
Normal weight (18.5 to <25) 5137 (37.78) 668 (32.47) 1019 (31.83)
Overweight (25 to <30) 5884 (43.27) 850 (41.32) 1288 (40.24)
Class I obese (30 to <35) 1844 (13.56) 396 (19.25) 621 (19.40)
Class II obese (35 to <40) 372 (2.74) 83 (4.04) 178 (5.56)
Class III obese (≥40) 82 (0.60) 29 (1.41) 60 (1.87)
Waist circumference*
Normal weight 6787 (70.88) 645 (51.68) 1142 (55.93) <0.001
Overweight 1676 (17.50) 285 (22.84) 357 (17.48)
Obese 1113 (11.62) 318 (25.48) 543 (26.59)
Waist-to-hip ratio*
Normal weight 3219 (33.62) 394 (31.57) 658 (32.22) 0.002
Overweight 5528 (57.73) 768 (61.54) 1171 (57.35)
Obese 828 (8.65) 86 (6.89) 213 (10.43)
*n for waist circumference and waist-to-hip ratio is 12 865.
BP, blood pressure.
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highest in age 51–60 years (26.03%, p<0.001), no formal 
education (17.73%, p<0.001), class III obese (32.19%, 
p<0.001) and with a positive family history of diabetes 
(31.34%, p<0.001) (figure 1). There were also statistically 
significant differences in diabetes prevalence by gender 
(female 17.85%, p=0.01), rural/urban (rural 19.09%, 
p<0.001) and smoking status (p=0.008).
On univariate logistic regression analysis, there was a 
significant association between age, gender, education, 
BMI category, family history, blood pressure and type 2 
diabetes (p<0.005) (table 2).
On multivariate logistic regression, there was signifi-
cantly higher risk of diabetes with age (adjusted OR 2.03, 
95% CI 3.39 to 4.87 and 4.93, p<0.001, aged 31–40, 41–50, 
51–60 and 61 years and above, respectively, compared 
with aged 20–30 years), BMI (adjusted OR 1.54, 95% 
CI 2.13 to 2.44, p<0.001 for class I, class II and class III 
obese, respectively, compared with normal weight) with 
evidence of a dose-response relationship. Similarly, there 
was a significantly higher risk of diabetes with lower 
educational attainment (adjusted OR 1.83, 95% CI 1.39 
to 1.57, no formal education, primary and secondary 
education, respectively, compared with graduates). There 
was a significantly higher risk of diabetes in people with 
a positive family history (adjusted OR 3.94, 95% CI 3.6 to 
4.3, p<0.001), than with no family history of diabetes. 
There was no significant association with smoking and 
rural/urban area.
Among 1029 participants who were tested for 2-hour 
OGTT, in addition to HbA1c, the mean 2-hour OGTT 
was 200.26 (SD 91.7), and the median was 178 (IQR 100). 
Taking the OGTT as the gold standard, HbA1c recom-
mended cut-off for diabetes showed a sensitivity of 84.7% 
(95% CI 80.8 to 88) and specificity of 87.2% (95% CI 
84.3 to 89.8%), area under the ROC 0.86 (95% CI 0.84 to 
0.88), positive predictive value 81.9% (95% CI 77.9 to 
85.4) and negative predictive value 89.3 (95% CI 86.5 to 
91.6) (table 3).
DisCussiOn
This is the first community-based national study done in 
the region based on HbA1c and with the eligible 18 856 
subjects from that country makes this as the largest study 
to date from Pakistan. The prevalence of type 2 diabetes 
across Pakistan was 16.98% (95% CI 16.44 to 17.51) and 
prediabetes was 10.91% (95% CI 10.46 to 11.36). This is 
Figure 1 Prevalence of diabetes (diagnosed by glycated haemoglobin (HbA1c) ≥6.5% diabetes control and complication 
trial (DCCT) aligned/48 mmol/mol IFFC units) by regions of Pakistan, age, gender, education, family history of diabetes, 
hypertension, waist circumference, waist-to-hip ratio and body mass index (n=18 856). KP, Khyber Pakhtunkhwa.
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Table 2 Logistic regression analysis of the participant characteristics associated with having diabetes (HbA1c≥6.5% DCCT 
aligned/48 mmol/mol IFFC units) (n=18 856)
Univariate Multivariate
OR (95% CI) P value OR (95% CI) P value
Age (years)
20–30 1 1
31–40 2.21 (1.8 to 2.6) <0.001 2.03 (1.7 to 2.4) <0.001
41–50 3.93 (3.3 to 4.6) <0.001 3.39 (2.9 to 4.0) <0.001
51–60 5.97 (5.0 to 7.1) <0.001 4.87 (4.1 to 5.8) <0.001
61 and above 5.63 (4.7 to 6.7) <0.001 4.93 (4.1 to 6.0) <0.001
Gender
Male 1 1
Female 1.12 (1.0 to 1.2) 0.003 1.04 (0.9 to 1.1) 0.334
Education
No formal education 2.02 (1.6 to 2.4) <0.001 1.83 (1.5 to 2.3) <0.001
Primary 1.85 (1.49 to 2.3) <0.001 1.39 (1.1 to 1.8) 0.006
Secondary 1.89 (1.47 to 2.4) <0.001 1.57 (1.2 to 2.0) 0.001
Graduation 1 1
Area
Urban 1 1
Rural 1.26 (1.16 to 1.34) <0.001 1.08 (0.9 to 1.2) 0.084
Family history
Negative 1 1
Positive 3.98 (3.6 to 4.3) <0.001 3.94 (3.6 to 4.3) <0.001
Smoking
Never 1 1
Ex-smoker 1.39 (1.1 to 1.8) 0.006 1.13 (0.9 to 1.5) 0.323
Current smoker 1.13 (0.9 to 1.3) 0.14 1.06 (0.9 to 1.3) 0.571
Systolic BP 1.02 (1.021 to 1.026) <0.001 1.01 (1.01 to 1.02) <0.001
Diastolic BP 1.01 (1.01 to 1.02) <0.001 0.99 (0.9 to 1.0) 0.310
BMI (kg/m2)
Underweight (<18.5) 0.64 (0.4 to 0.9) 0.001 0.71 (0.5 to 1.0) 0.077
Normal weight (18.5 to <25) 1 1
Overweight (25 to <30) 1.08 (0.9 to 1.2) 0.06 1.06 (0.9 to 1.1) 0.182
Class I obese (30 to <35) 1.57 (1.4 to 1.7) <0.001 1.54 (1.3 to 1.7) <0.001
Class II obese (35 to <40) 2.22 (1.8 to 2.6) <0.001 2.13 (1.7 to 2.6) <0.001
Class III obese (≥40) 3.07 (2.2 to 4.2) <0.001 2.44 (1.7 to 3.5) <0.001
WC*
Normal weight 1 1
Overweight 1.18 (1.04 to 1.34) 0.01 0.98 (0.8 to 1.1) 0.774
Obese 2.46 (2.19 to 2.77) <0.001 1.86 (1.6 to 2.2) <0.001
WHR*
Normal weight 1 1
Overweight 1.02 (0.92 to 1.13) 0.40 0.8 (0.7 to 0.9) <0.001
Obese 1.27 (1.07 to 1.51) 0.005 1.13 (0.9 to 1.4) 0.205
*n for WC and WHR is 12 865. The following variables were included in the multivariate regression: age, gender, education, residence area, 
family history of diabetes, smoking, systolic BP and diastolic BP and BMI.
BMI, body mass index; BP, blood pressure; DCCT, diabetes control and complication trial; HbA1c, glycated haemoglobin; WC, waist 
circumference; WHR, waist-to-hip ratio. 
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higher than found in the only previous national survey 
conducted in1999 (n=5433) using OGTT. There was a 
significantly higher risk of type 2 diabetes with increasing 
systolic blood pressure, age, BMI, WC, WHR with evidence 
of a dose-response relationship. Similarly, there was a 
significant inverse relationship of type 2 diabetes with the 
level of formal education. The risk of diabetes increased 
2.68 times with a prior family history. The HbA1c level 
had good sensitivity and specificity level for the diagnosis 
of type 2 diabetes compared with a 2-hour OGTT level 
and is therefore valid in community settings for screening 
purposes.
We have noted the findings of Basit et al.15 The meth-
odology for that recently published study was based on 
75 g OGTT for glucose handling as opposed to HbA1c 
used in our study. While the prevalence of diabetes and 
prediabetes is different in the two studies, the point that 
both studies make is that both diabetes and prediabetes 
are much more prevalent than previously thought.
The previous national prevalence study conducted in 
1999 used OGTT where almost 80% of the subjects were 
women as the test was conducted in the morning time.4 
In contrast, our study screening was done all through the 
day so that working men had an equal opportunity to be 
part of the study. They constituted 50% of the study popu-
lation. OGTT is the gold standard for the type 2 diabetes 
screening but because of the length of time which is 
required for the test and the fact that the person must 
be fasting, it is very difficult to perform in many commu-
nity settings in Pakistan. Also, the high temperatures in 
South Asia make it difficult to keep the sample stable for 
transportation to the laboratory. To minimise the effect of 
temperature and transportation errors on HbA1c, all tests 
were conducted in the field.
Recently, a study carried out in 15 states of India showed 
that the prevalence of type 2 diabetes ranged between 4% 
and 13.6% and showed variation due to age, male sex, 
obesity and family history using capillary fasting blood 
glucose (FBG) for diagnosis.16 A capillary blood sample 
for epidemiological studies is not an ideal test but the 
authors acknowledged the logistic hindrance in carrying 
out venous sample test in the field. A high prevalence in 
another Indian study was reported ranging from 12.1% to 
14% for diabetes using OGTT on a sample size of 11 216 
subjects.17
A study conducted in Bangladesh based on capillary 
fasting level found a prevalence of type 2 diabetes of 4.3% 
in a rural setting.18 Risk factors were positive family history 
for diabetes, age, high BMI and low socioeconomic status, 
similar to our study. Although these are geographically 
distant areas, the risk factors showed commonality in both 
studies, which suggests these risk factors as an important 
tool for mass screening.19
The age-standardised and sex-standardised prevalence 
of type 2 diabetes for Sri Lankans was 10.3% based on 
OGTT.20 The risk factors were almost the same as seen in 
our study. The investigators found dysglycaemia in almost 
21.8% participants and predicted that this would lead to a 
higher prevalence of type 2 diabetes mellitus in the years 
to come. Another study from Sri Lanka indicated a prev-
alence of 14.2% basis of FBG.21 FBG as well as, OGTT 
blood glucose levels, may not be reproducible in an epide-
miological survey if the individual are changing lifestyle 
in terms of diet and exercise. The use of HbA1c in our 
study makes our study more scientific, addressing issues 
pertaining to sampling errors in the local environment.
The Asian population is known to have a significantly 
higher risk of developing diabetes and its related compli-
cations as predicted by IDF projections.1 It makes it very 
important from a public health point of view to identify 
high-risk individuals at an early stage. The HbA1c test has 
been used successfully in community settings.22 A national 
health survey in New Zealand in 2008–2009 used HbA1c 
to identify high-risk individuals with diabetes and predia-
betes.23 A study in Japan revealed that a combination of 
tests including FBG and HbA1c yields more diabetes cases 
compared with any of these tests alone.24
WHO experts have accepted HbA1c as a diagnostic tool 
provided quality assurance tests are in place and there 
are no conditions present, which preclude its accurate 
Table 3 Summary statistics for diabetes diagnosed by HbA1c  compared with diabetes diagnosed by 2-hour OGTT (n=1027)
95% CI
Prevalence Pr (A) 40.6% 37.6 43.7
Sensitivity Pr (+|A) 84.7% 80.8 88.0
Specificity Pr (−|N) 87.2% 84.3 89.8
Area under the ROC (Sens.+Spec.)/2 0.86 0.84 0.88
Likelihood ratio (+) Pr (+|A)/Pr (+|N) 6.62 5.36 8.18
Likelihood ratio (−) Pr (−|A)/Pr (−|N) 0.18 0.14 0.22
OR LR (+)/LR (−) 37.62 26.34 53.73
Positive predictive value Pr (A|+) 81.9% 77.9 85.4
Negative predictive 
value
Pr (N|−) 89.3% 86.5 91.6
HbA1c, glycated haemoglobin; OGTT, oral glucose tolerance test; ROC, receiver operating characteristic. 
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measurement. The New Zealand Society for the study 
of diabetes and the Australian Diabetes Society have 
already endorsed HbA1c as a test for the diagnosis of 
diabetes.25 26 Recently, a prevalence study done in Korea 
concluded that FBG testing results in underestimation of 
diabetes and prediabetes.27 This study suggested the use 
of standardised HbA1c as a diagnostic tool for diagnosis 
of type 2 diabetes.
We found that HbA1c had a good sensitivity and spec-
ificity level for diagnoses of diabetes compared with the 
OGTT. HbA1c has the advantage of being a simple test 
and less time-consuming, making it an ideal test for 
community surveys in our populations. In Pakistan, as 
there is no effective primary care (general/family prac-
tice) structure most of the population does not undergo 
primary screening for diabetes. Sometimes as the diag-
nosis is not made, people may present to tertiary care with 
complications.
Thus, there is a strong case for applying HbA1c for 
screening purposes in the community setting. There 
will always be an argument about the cost of the test and 
whether this to be used for screening purposes. However, 
particularly those at social disadvantage need to undergo 
screening to improve the diagnosis and timely treatment 
of diabetes.28 Early diagnosis will also reduce diabetes-re-
lated complications.
strengths and limitations
Our study has the strength that we carried out HbA1c on 
all participants and OGTT on a subsample. Furthermore, 
this is the largest ever national prevalence study of type 2 
diabetes mellitus from Pakistan and the first communi-
ty-based national study to use HbA1c as the diagnostic 
tool.
Limitations are the relatively low number (n=1027) of 
75 g OGTT. Nevertheless, the specificity and sensitivity of 
HbA1c versus OGTT was good. We had to exclude 16% of 
recruited participants because of anaemia.
The central Government of Pakistan developed and 
agreed on non-communicable diseases (NCD) National 
Action Plan including diabetes; however, it was never 
implemented. After the 18th Amendment in the consti-
tution of Pakistan in 2010, provinces are responsible for 
making and implementing their own health policies and 
the role of central Government is limited to coordina-
tion among the different provinces.29 There is a dire 
need that based on the agreed NCD National Action 
Plan each province should build their capacity for imple-
menting it at both primary and secondary level. Pakistan 
is a signatory to the Sustainable Development Goals 2030 
document, which outlines among its goals, increasing 
access to universal health coverage, increasing coverage 
of health insurance programme and adopting a family 
medicine approach. When implemented, these will be 
major steps towards prevention and control of diabetes 
and all NCD.
COnClusiOns
This national diabetes prevalence study is the first one in 
the region using HbA1c identified a huge population of 
type 2 diabetes and prediabetes group. The prevalence 
of type 2 diabetes and prediabetes is much higher than 
previously thought in Pakistan. Comprehensive strategies 
need to be developed to incorporate screening, preven-
tion and treatment of type 2 diabetes at community level. 
Those who are obese, with no formal education, older, 
family history of diabetes and hypertensive merit close 
attention and timely intervention.
HbA1c is an applicable test in community settings in 
middle-income and low-income countries and it has a 
good correlation with 2-hour OGTT. Our findings have 
the potential to influence policy in middle-income and 
low-income countries and induce a shift towards the 
prevention and control of NCD.
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